Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  1993-10-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.1993.03510150060030PMID 8411526
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pneumococcal antibodies (IgG, IgM) in patients with chronic obstructive lung disease 3 years after pneumococcal vaccination

  2005cited by this paper
• ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS PNEUMONIAE: AN OVERVIEW

  1993cited by this paper
• Mechanisms of host defense against infection with Streptococcus pneumoniae.

  1992cited by this paper
• Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment.

  1992cited by this paper
• Antimicrobial resistance in Streptococcus pneumoniae: an overview.

  1992cited by this paper
• Update on adult immunization. Recommendations of the Immunization Practices Advisory Committee (ACIP).

  1991cited by this paper
• The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

  1991cited by this paper
• Immunologic system in the respiratory tract.

  1991cited by this paper
• Severe community-acquired pneumonia. Epidemiology and prognostic factors.

  1991cited by this paper
• Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.

  1991cited by this paper
• Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group.

  1991cited by this paper
• Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

  1990cited by this paper
• New and Emerging Etiologies for Community‐Acquired Pneumonia with Implications for Therapy: A Prospective Multicenter Study of 359 Cases

  1990cited by this paper
• Pneumococcal vaccination: work to date and future prospects.

  1990cited by this paper
• The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.

  1990cited by this paper
• Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?

  1990cited by this paper
• Invasive pneumococcal disease in an Alaska native population, 1980 through 1986.

  1989cited by this paper
• The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly

  1988cited by this paper
• The clinical effectiveness of pneumococcal vaccine in the elderly.

  1988cited by this paper
• Immunization policies and vaccine coverage among adults. The risk for missed opportunities.

  1988cited by this paper
• Influenza and pneumococcal immunization strategies for physicians.

  1987cited by this paper
• Pneumococcal Antibody Levels One Decade After Immunization of Healthy Adults

  1987cited by this paper
• Pneumococcal vaccine failure.

  1986cited by this paper
• Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.

  1986cited by this paper
• Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine.

  1986cited by this paper
• A general estimator for the variance of the Mantel-Haenszel odds ratio.

  1986cited by this paper
• Breakthrough of cytomegalovirus infection despite 9-(1,3-dihydroxy-2-propoxymethyl)guanine therapy.

  1986cited by this paper
• Pneumococcal vaccine and isolates for the Centers for Disease Control.

  1986cited by this paper
• Pneumococcal vaccine efficacy in selected populations in the United States.

  1986cited by this paper
• Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine.

  1985cited by this paper
• A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.

  1984cited by this paper
• Reactivity and Antibody Responses of Volunteers Given Two or Three Doses of Pneumococcal Vaccine

  1984cited by this paper
• Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.

  1984cited by this paper
• Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination.

  1984cited by this paper
• A reassessment of pneumococcal vaccine.

  1984cited by this paper
• Resolving the pneumococcal vaccine controversy: are there alternatives to randomized clinical trials?

  1984cited by this paper
• Update: pneumococcal polysaccharide vaccine usage--United States.

  1984cited by this paper
• Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

  1983cited by this paper
• Antibody Responses after Immunization with Polyvalent Pneumococcal Vaccine Containing 10, 25, or 50 μg of 14 Polysaccharide Types per Dose

  1983cited by this paper
• Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

  1983cited by this paper
• Reactions to booster pneumococcal vaccination in patients with sickle cell disease

  1983cited by this paper
• Long-Term Persistence of Antibody following Immunization with Pneumococcal Polysaccharide Vaccine 1

  1983cited by this paper
• Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination

  1982cited by this paper
• Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.

  1982cited by this paper
• The epidemiology of pneumococcal disease in infants and children.

  1981cited by this paper
• Response to pneumococcal vaccine in renal transplant and hemodialysis patients.

  1981cited by this paper
• Assessment of the antibody response to pneumococcal vaccine in high-risk populations.

  1981cited by this paper
• Pneumococcal vaccine failure.

  1981cited by this paper
• Antibody response to pneumococcal vaccine in patients with multiple myeloma.

  1981cited by this paper
• Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States.

  1981cited by this paper
• Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines.

  1981cited by this paper
• Pneumococcal Disease after Pneumococcal Vaccination

  1980cited by this paper
• Persistence of Pneumococcal Antibodies in Human Subjects following Vaccination

  1980cited by this paper
• Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine.

  1980cited by this paper
• Response of patients with Hodgkin's disease to pneumococcal vaccine.

  1979cited by this paper
• Pneumococcal Vaccine: Dose, Revaccination, and Coadministration with Influenza Vaccine

  1979cited by this paper
• Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants

  1978cited by this paper
• Protective efficacy of pneumococcal polysaccharide vaccines.

  1977cited by this paper
• Prevention of pneumococcal pneumonia by vaccination.

  1976cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper
• PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

  1964cited by this paper

• Immune persistence of a single dose of 23-valent pneumococcal polysaccharide vaccine: A 6-year follow-up

  2025cites this paper
• Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine

  2024cites this paper
• Persistence of antibody to 23-valent pneumococcal polysaccharide vaccine: a 5-year prospective follow-up cohort study

  2024cites this paper
• Updated Recommendations on the Prevention and Treatment of Infections in Children With Asplenia/Hyposplenism

  2024cites this paper
• Diabetes as a risk factor for pneumococcal disease and severe related outcomes and efficacy/effectiveness of vaccination in diabetic population. Results from meta-analysis of observational studies

  2024cites this paper
• Modelling control strategies for pneumococcal meningitis outbreaks in the African meningitis belt.

  2024cites this paper
• Naturally acquired antibodies against 4 Streptococcus pneumoniae serotypes in Pakistani adults with type 2 diabetes mellitus

  2024cites this paper
• The durability of vaccine-induced protection: an overview

  2024cites this paper
• Antibody enhanced HPLC for serotype-specific quantitation of polysaccharides in pneumococcal conjugate vaccine

  2023cites this paper
• Increasing pneumococcal vaccine uptake in older adults: a scoping review of interventions in high-income countries

  2023cites this paper
• Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial.

  2023cites this paper
• Effectiveness of pneumococcal vaccination on hospitalization and death in the adult and older adult diabetic population: a systematic review

  2023cites this paper
• 2023 Guidelines of the Taiwan Society of Cardiology on the Diagnosis and Management of Chronic Coronary Syndrome.

  2023cites this paper
• A Study to Assess the Effectiveness of Video Assisted Teaching Programme (VATP) on Knowledge of Prevention of Pneumonia among Parents Attending Pediatric Outpatient Department (OPD) in Selected Hospital at Jabalpur

  2023cites this paper
• Subunit-based vaccines

  2022cites this paper
• Applying differential network analysis to longitudinal gene expression in response to perturbations

  2022cites this paper
• Materials‐based vaccines for infectious diseases

  2022cites this paper
• Differential Network Analysis of Longitudinal Gene Expression in Response to Perturbations

  2021cites this paper
• Chronic Disease and Immunosuppression Increase the Risk for Nonvaccine Serotype Pneumococcal Disease: A Nationwide Population-based Study

  2021cites this paper
• Whole-Cell Vaccine Preparation: Options and Perspectives.

  2021cites this paper
• COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges

  2021cites this paper
• Review on Pneumococcal Infection in Children

  2021influential citation
• Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis.

  2020cites this paper
• Diabetes mellitus as a vaccine-effect modifier: a review

  2020cites this paper
• Impact of 23‐valent pneumococcal polysaccharide vaccination on the frequency of pneumonia‐related hospitalization and survival in elderly patients with prostate cancer: A seven‐year nationwide matched cohort study

  2020cites this paper
• Splenic Artery Embolization for Nonocclusive Hepatic Artery Hypoperfusion

  2020cites this paper
• Awareness, attitude, and knowledge about pneumococcal infection and vaccination: A survey across North Delhi

  2020cites this paper
• Low Baseline Pneumococcal Antibody Titers Predict Specific Antibody Deficiency, Increased Upper Respiratory Infections, and Allergy Sensitization

  2020cites this paper
• Comparison of Two Different Criteria for Specific Antibody Deficiency in Patients With Chronic and Recurrent Rhinosinusitis

  2020cites this paper
• Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.

  2019cites this paper
• Development of a new immunoliposome drug delivery system for treatment of pneumococcal meningitis

  2019cites this paper
• Efficacy of Pneumococcal Vaccine

  2019cites this paper
• Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly patients with colorectal cancer

  2019cites this paper
• Rocking Pneumonia and the Boogie Woogie Flu

  2019cites this paper
• The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology.

  2019cites this paper
• Validation of a Multiplexed Opsonophagocytic Assay for 11 Additional Pneumococcal Serotypes and Its Application to Functional Antibody Evaluation Induced by Pneumococcal Polysaccharide Vaccine

  2018cites this paper
• Role of Splenic Artery Embolization in Gastric Variceal Hemorrhage due to Sinistral Portal Hypertension

  2018cites this paper
• Predictors of mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring ICU admission

  2018cites this paper
• The role of pneumococcal vaccine: Review article

  2018cites this paper
• 47 – Pneumococcal Polysaccharide Vaccines

  2018cites this paper
• Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia

  2018cites this paper
• Impact of medical and/or pharmacy reimbursement on adult vaccination rates.

  2018cites this paper
• Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention

  2018cites this paper
• Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017

  2018cites this paper
• A cost-effectiveness analysis of revaccination and catch-up strategies with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in older adults in Japan

  2018cites this paper
• Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective

  2017cites this paper
• Lymphoid Hematopoiesis and the Role of B-cells in Transgenic Mouse Model of Sickle Cell Disease

  2017cites this paper
• Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia.

  2017cites this paper
• Failure to Vaccinate Medicare Inpatients

  2017cites this paper
• Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.

  2017cites this paper
• Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model

  2016cites this paper
• Effect of exercise therapy on cytokine secretion in the saliva of bedridden patients

  2016cites this paper
• Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes

  2016cites this paper
• Vaccine profile of PPV23: Beijing Minhai Biotech 23-valent pneumococcal vaccine

  2016cites this paper
• Fatal infection in adults by pneumolysin & autolysin producing, non-vaccine serotype Streptococcus pneumonia

  2016cites this paper
• Contemporary Management of Chronic Obstructive Pulmonary Disease

  2016cites this paper
• Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis.

  2016cites this paper
• The Saudi Thoracic Society pneumococcal vaccination guidelines-2016

  2016cites this paper
• Longterm Efficacy of an Antipneumococcal Polysaccharide Vaccine among Patients with Autoimmune Inflammatory Rheumatic Diseases

  2016cites this paper
• Unwarranted Pneumococcal Vaccination in an Acute Care Hospital Related to Core Quality Measure Initiatives

  2016cites this paper
• Knowledge and Attitude toward Pneumonia and Pneumococcal Polysaccharide Vaccine among the Elderly in Shanghai, China: A Cross-sectional Questionnaire Survey

  2016cites this paper
• Australian and New Zealand Society for Geriatric Medicine Position Statement – Immunisation of older people

  2016cites this paper
• The effect of Zinc on the Immune responses of pneumococcal vaccination in elderly

  2016cites this paper
• Respiratory Infection, Airway Colonization and Chronic Inflammation in Aging

  2016cites this paper
• Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers

  2016cites this paper
• Should Committees That Write Guidelines and Recommendations Publish Dissenting Opinions?

  2016cites this paper
• Risk Factors for Pneumonia and the Effect of the Pneumococcal Vaccine in Patients With Chronic Airflow Obstruction.

  2016cites this paper
• Prevalence of Influenza and Pneumococcal-23 Vaccination in Pediatric Patients with Renal Disease: A Single Urban Center Experience

  2016cites this paper
• Pneumococcal vaccine for preventing Streptococcus pneumoniae infection in HIV‐infected individuals

  2016cites this paper
• Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model

  2016cites this paper
• PURIFICAÇÃO DO POLISSACARÍDEO CAPSULAR DE STREPTOCOCCUS PNEUMONIAE DE SOROTIPO 14

  2015cites this paper
• Unwarranted Pneumococcal Vaccination in an Acute Care Hospital Related to Core Quality Measure Initiatives

  2015cites this paper
• [Pneumococcal infections: Appraisal and perspectives in terms of adult vaccination].

  2015cites this paper
• Telaprevir-based triple therapy following partial splenic arterial embolization for chronic hepatitis C with thrombocytopenia can reduce carcinogenesis and improve hepatic function reserve

  2015cites this paper
• NEUMONÍA ADQUIRIDA DE LA COMUNIDAD EN ADULTOS. RECOMENDACIONES SOBRE SU ATENCIÓN

  2015cites this paper
• Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough

  2015cites this paper
• [Guidelines for management of community-acquired pneumonia in adults].

  2015cites this paper
• Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults

  2015cites this paper
• Prevalence of Resistant Strains of Streptococcus Pneumoniae to Oxacillin, Ofloxacin and Rifampicin in Abraka South-South Nigeria

  2015cites this paper
• Pneumococcal Vaccine in Diabetes: Relevance in India.

  2015cites this paper
• Pneumococcal vaccination in older adults in the era of childhood vaccination: Public health insights from a Norwegian statistical prediction study.

  2015cites this paper
• Community Acquired Pneumonia

  2015cites this paper
• Expectations for partial splenic arterial embolization simultaneous transcatheter arterial chemoembolization for hepatocellular carcinoma

  2015cites this paper
• Análise do Impacto na redução de pneumonia adquirida na comunidade em crianças após a introdução da vacina antipneumocócica 10-valente no Programa Nacional de Imunização.

  2015cites this paper
• Pneumococcal Vaccine in Diabetes: Relevance in India.

  2015cites this paper
• Expedient Synthesis of the Pentasaccharide Repeating Unit of the Polysaccharide O‐Antigen of Escherichia coli O11

  2015cites this paper
• The effect of various types of patients' reminders on the uptake of pneumococcal vaccine in adults: A randomized controlled trial.

  2015cites this paper
• Pneumococcal vaccine and patients with pulmonary diseases.

  2014cites this paper
• A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older

  2014cites this paper
• An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine

  2014cites this paper
• Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis

  2014cites this paper
• Cost-Effectiveness Analysis of Pneumococcal Vaccination with the Pneumococcal Polysaccharide NTHi Protein D Conjugate Vaccine in the Philippines.

  2014cites this paper
• Cost–effectiveness of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK

  2014cites this paper
• Effects of Flu Vaccine, Solely or Accompanied by Pneumovax-23 Vaccine on clinical Consequences of the Respiratory Diseases among Iranian Pilgrims in Hajj

  2014cites this paper
• 27 – Bacterial Meningitis

  2014cites this paper
• Best practice in nursing care of dyspnea: The 6th vital sign in individuals with COPD

  2013cites this paper
• Extraction of Polysaccharides from Saccharomyces cerevisiae and its Immune Enhancement Activity

  2013cites this paper
• Additive preventive effect of influenza and pneumococcal vaccines in the elderly

  2013cites this paper
• Prevalence of Howell-Jolly bodies caused by partial splenic embolization for portal hypertension.

  2013cites this paper
• Neumonía neumocócica por el serotipo 3 complicada

  2013cites this paper